- 专利标题: Method of fixing and expressing physiologically active substance
-
申请号: US16869812申请日: 2020-05-08
-
公开(公告)号: US11485974B2公开(公告)日: 2022-11-01
- 发明人: Hiroyuki Yoneyama , Kenji Suzuki
- 申请人: STELIC INSTITUTE & CO. , (NATIONAL UNIVERSITY CORPORATION) NIIGATA UNIVERSITY
- 申请人地址: JP Tokyo; JP Niigata
- 专利权人: STELIC INSTITUTE & CO.,(NATIONAL UNIVERSITY CORPORATION) NIIGATA UNIVERSITY
- 当前专利权人: STELIC INSTITUTE & CO.,(NATIONAL UNIVERSITY CORPORATION) NIIGATA UNIVERSITY
- 当前专利权人地址: JP Tokyo; JP Niigata
- 代理机构: Oblon, McClelland, Maier & Neustadt, L.L.P.
- 优先权: JP2007-171361 20070629
- 主分类号: C07H21/04
- IPC分类号: C07H21/04 ; C12N15/113 ; A61K9/00 ; A61K9/08 ; A61K9/10 ; A61K31/396 ; A61K31/7088 ; A61K31/7105 ; A61K48/00 ; A61P9/10 ; A61P1/00 ; A61P17/02 ; A61P19/02 ; A61K31/713
摘要:
The present invention provides methods for retaining and expressing physiologically active substances in a target tissue-specific-manner, by administering the physiologically active substances to target submucous tissue. Specifically, the present inventors demonstrated that, when physiologically active substances were directly administered into submucous tissues without using a carrier, the physiologically active substances were effectively and safely retained at the administration sites over long periods without loss and diffusion, and produced the effect acting in a reservoir-like fashion. The physiologically active substances administered as described above were demonstrated to produce the therapeutic effect without having an influence on organs other than the administered organ.
公开/授权文献
信息查询